Psoriatic arthritis links skin psoriasis with joint pain and swelling. Learn the key signs like dactylitis and nail changes, how it differs from rheumatoid arthritis, and the latest treatments that can prevent joint damage.
I recently came across some fascinating new research on the potential uses of Ticlopidine, a medication traditionally prescribed to prevent blood clots. Scientists are now exploring its potential in treating other medical conditions, such as Parkinson's disease and certain types of cancer. It's exciting to see how researchers are constantly pushing the boundaries of medical knowledge and discovering unexpected applications for existing drugs. I'll be keeping a close eye on the progress of these studies and will keep you all updated on any significant developments. Who knows, Ticlopidine could soon play a crucial role in the treatment of a whole new range of diseases!
Paul Jessup, the ex-managing director of Strand Capital SA, has been disqualified from serving as a company director for nine years. The Insolvency Service found him guilty of misusing funds from Helvetica Investments Ltd, leading to a significant financial shortfall and his subsequent disqualification.
Find practical tips and facts on switching from Symbicort to Advair: dosage conversion, side effects, and insurance authorization. Get smart, hands-on guidance here.
Learn practical steps to prevent skin yeast infections, from hygiene and clothing tips to diet and early detection, plus when to seek medical help.
In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.